Showing results (21-30 of 110) with videos related to
Sort By:
Pageof 11
Cost Effectiveness and Resource Allocation : C/E|September 10, 2020
Establishing a reasonable price for an orphan drugMikel Berdud, Michael Drummond, Adrian TowseThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 17, 2025
Pricing combination products: not how but who?Adrian Towse, Andrew Briggs, Lotte SteutenInternational Journal of Technology Assessment in Health Care|May 31, 2017
ASSESSING VALUE, BUDGET IMPACT, AND AFFORDABILITY IN ASIAGrace Hampson, Chris Henshall, Adrian TowsePharmacoeconomics - Open|July 2, 2025
Missing Pieces of the Puzzle to Address Market Failures for Antibiotics: Delinked Payment Systems and Insurance ValueNeil Hawkins, Adrian Towse, Amanda AdlerFrontiers in Health Services|September 11, 2023
A theory on ICER pricing and optimal levels of cost-effectiveness thresholds: a bargaining approachMikel Berdud, Jimena Ferraro, Adrian TowseHealth and Social Care Delivery Research|June 28, 2024
Service innovations for people with multiple long-term conditions: reflections of a rapid evaluation teamJon Sussex, Judith Smith, Frances M WuHealth Policy (Amsterdam, Netherlands)|January 19, 2012
Managing poorly performing clinicians: health care providers' willingness to pay for independent helpVerity Watson, Jon Sussex, Mandy Ryan, et al.BJGP Open|January 8, 2024
Impact of vertical integration on patients' use of hospital services in England: an analysis of activity dataCatherine Saunders, Charlotte Davies, Manbinder Sidhu, et al.Health Economics|December 12, 2013
Value-based differential pricing: efficient prices for drugs in a global contextPatricia Danzon, Adrian Towse, Jorge Mestre-FerrandizPharmacoeconomics|January 22, 2016
Biosimilars: How Can Payers Get Long-Term Savings?Jorge Mestre-Ferrandiz, Adrian Towse, Mikel BerdudPageof 11